Pluri
Orly Amiran has extensive experience in quality assurance and regulatory affairs in the pharmaceutical industry. Orly held the role of VP Quality Affairs at Pluristem Therapeutics from 2012 onwards. Prior to that, they worked at Teva Pharmaceutical Industries Ltd. as a Quality Assurance Manager, overseeing the quality system in an oral solid plant. Orly also supported projects related to quality improvements and regulatory agency inspections. Before joining Teva, Orly was the Compliance and Quality Development Manager at Taro Pharmaceutical Industries, where they were responsible for compliance activities and supported regulatory agency inspections. Orly also worked as a Quality and Regulatory Affairs professional at Taro Pharmaceuticals from 2001 to 2004.
Orly Amiran completed a Bachelor of Science in Pharmacy from The Hebrew University of Jerusalem, where they studied from 1997 to 2001. Orly later attended Technion - Israel Institute of Technology from 2002 to 2005 and obtained a Master's degree in Quality Assurance.
Pluri
3 followers
Pluri is pushing the boundaries of science and engineering to create cell-based products for commercial use and is pioneering a biotech revolution that promotes global wellbeing and sustainability. The Company’s technology platform, a patented and validated state-of-the-art 3D cell expansion system, advances novel cell-based solutions for a range of initiatives— from medicine and climate change to food scarcity, animal cruelty and beyond. Pluri’s method is uniquely accurate, scalable, cost-effective, and consistent from batch to batch. Pluri currently operates in the field of regenerative medicine and food-tech and aims to establish partnerships that leverage the company’s 3D cell-based technology to additional industries that require effective, mass cell production. To learn more, visit us at www.pluri-biotech.com or follow us on LinkedIn and Twitter.